Physician profile
Dennis E Smith
NPI 1245279918
$1,193.06
in general payments reported to CMS, 2019-2025
21 companies · $326 in 2025
The $326 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $27.21 · 2021: $99.29 · 2022: $226 · 2023: $139 · 2024: $251 · 2025: $326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $716.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $716.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $274.11 | 2023-2025 | Rexulti |
| Pfizer INC. | $162.46 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $137.99 | 2020-2023 | Xarelto |
| Abbvie INC. | $86.15 | 2021-2025 | Vraylar |
| Novo Nordisk INC | $68.53 | 2019-2024 | |
| Inspire Medical Systems, INC. | $54.52 | 2024 | Inspire |
| Medtronic USA, INC. | $50.55 | 2019 | |
| Boston Scientific Corporation | $48.65 | 2022-2025 | Watchman Flx |
| Averitas Pharma INC. | $39.60 | 2023 | Qutenza |
| Novartis Pharmaceuticals Corporation | $37.94 | 2019-2022 | |
| Xeris Pharmaceuticals, INC. | $37.43 | 2024-2025 | Gvoke Hypopen |
| Astellas Pharma US INC | $37.18 | 2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $34.89 | 2022-2025 | |
| Teva Pharmaceuticals USA, INC. | $27.41 | 2019 | |
| Alexion Pharmaceuticals, INC. | $21.76 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.89 | 2024 | Ofev |
| Dexcom, INC. | $17.49 | 2025 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals Lp | $16.58 | 2025 | Airsupra |
| Glaxosmithkline, LLC. | $12.09 | 2022 | |
| Daxor Corporation | $3.63 | 2024 | Bva-100 |
| Phathom Pharmaceuticals, INC. | $3.21 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.